Long ABT: breakout from downtrend, heading towards resistance level with strong momentum and new FDA approvals
[#item_full_content]More
[#item_full_content]More
[#item_full_content]More
[#item_full_content]More
[#item_full_content]More
[#item_full_content]More
[#item_full_content]More
[#item_full_content]More
[#item_full_content]More
[#item_full_content]More
[#item_full_content]More